跳转至内容
Merck
CN
  • Contributions of NanI sialidase to Caco-2 cell adherence by Clostridium perfringens type A and C strains causing human intestinal disease.

Contributions of NanI sialidase to Caco-2 cell adherence by Clostridium perfringens type A and C strains causing human intestinal disease.

Infection and immunity (2014-08-20)
Jihong Li, Bruce A McClane
摘要

Previous studies showed that Clostridium perfringens type D animal disease strain CN3718 uses NanI sialidase for adhering to enterocyte-like Caco-2 cells. The current study analyzed whether NanI is similarly important when type A and C human intestinal disease strains attach to Caco-2 cells. A PCR survey determined that the nanI gene was absent from typical type A food poisoning (FP) strains carrying a chromosomal enterotoxin (CPE) gene or the genetically related type C Darmbrand (Db) strains. However, the nanI gene was present in type A strains from healthy humans, type A strains causing CPE-associated antibiotic-associated diarrhea (AAD) or sporadic diarrhea (SD), and type C Pig-Bel strains. Consistent with NanI sialidase being the major C. perfringens sialidase when produced, FP and Db strains had little supernatant sialidase activity compared to other type A or C human intestinal strains. All type A and C human intestinal strains bound to Caco-2 cells, but NanI-producing strains had higher attachment levels. When produced, NanI can contribute to host cell attachment of human intestinal disease strains, since a nanI null mutant constructed in type A SD strain F4969 had lower Caco-2 cell adhesion than wild-type F4969 or a complemented strain. Further supporting a role for NanI in host cell attachment, sialidase inhibitors reduced F4969 adhesion to Caco-2 cells. Collectively, these results suggest that NanI may contribute to the intestinal attachment and colonization needed for the chronic diarrhea of CPE-associated AAD and SD, but this sialidase appears to be dispensable for the acute pathogenesis of type A FP or type C enteritis necroticans.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
苯酚 溶液, Equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA, BioReagent, Molecular Biology
Sigma-Aldrich
苯酚, puriss., ≥99.5% (GC), meets analytical specification of Ph. Eur., BP, USP, crystalline (detached)
Sigma-Aldrich
硫代乙醇酸钠, ≥96.5% (iodometric)
Sigma-Aldrich
苯酚 溶液, Saturated with 0.01 M citrate buffer, pH 4.3 ± 0.2, BioReagent, Molecular Biology
Sigma-Aldrich
苯酚, ≥99%
Sigma-Aldrich
液状苯酚, ≥89.0%
Sigma-Aldrich
苯酚, puriss. p.a., ACS reagent, reag. Ph. Eur., 99.0-100.5%
Supelco
苯酚, Pharmaceutical Secondary Standard; Certified Reference Material
USP
苯酚, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
苯酚, Molecular Biology
Sigma-Aldrich
苯酚, BioXtra, ≥99.5% (GC)
Supelco
苯酚 溶液, certified reference material, 500 μg/mL in methanol
Sigma-Aldrich
苯酚, ACS reagent, ≥99.0%
Sigma-Aldrich
苯酚, unstabilized, ReagentPlus®, ≥99%
Sigma-Aldrich
苯酚, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (GC)
Supelco
苯酚 溶液, 5000 μg/mL in methanol, certified reference material
Sigma-Aldrich
苯酚, unstabilized, purified by redistillation, ≥99%
Sigma-Aldrich
苯酚, BioUltra, Molecular Biology, TE-saturated, ~73% (T)
Sigma-Aldrich
N-乙酰基-2,3-脱氢-2-脱氧神经氨酸, ≥93% (TLC)
Sigma-Aldrich
苯酚, natural, 97%, FG
Supelco
苯酚, PESTANAL®, analytical standard
Sigma-Aldrich
苯酚, ≥96.0% (calc. on dry substance, T)
Sigma-Aldrich
苯酚, BioUltra, Molecular Biology, ≥99.5% (GC)
Supelco
苯酚 溶液, 100 μg/mL in acetonitrile, PESTANAL®, analytical standard
Sigma-Aldrich
Siastatin B, lyophilized powder, from microbial